Medical/Pharmaceuticals
Havas Health & You Announces Expansion Across APAC, Including Southeast Asia (SEA) Village
SINGAPORE, Feb. 23, 2022 /PRNewswire/ -- In the next decade, APAC will represent 40% of total growth in global health spending, expanding at a rate almost double that of the rest of the world – making both presence and investment in APAC more critical than ever. To help Havas Health & You (HH&Y) ...
XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic System
The XACT ACE® Robotic System addresses the limitations of traditional manual methods and other image-guided percutaneous intervention systems. SAN ANTONIO, Feb. 22, 2022 /PRNewswire/ -- Frost & Sullivan recently evaluated the North American percutaneous procedure system industry and, based on it...
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution
BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement withHiroshima University, one of the top public universities inHiroshima City, Japan, to support their molecular profiling by next-generation sequencing ...
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company
SEOUL, South Korea, Feb. 22, 2022 /PRNewswire/ -- RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest global pharmaceutical companies Eli Lilly and Company (hereinafter referred to as "Eli Lilly...
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform
SUZHOU, China, and PALO ALTO, Calif., Feb. 22, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...
InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP
BEIJING, Feb. 22, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the first patient has been dosed in Phase II clinical trial of its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib for the treatment of primary immune thrombocyto...
4D IMAGING RADAR LEADER VAYYAR EXPANDS GLOBAL FOOTPRINT WITH NEW JAPAN OFFICE
- Vayyar Imaging's new office will open in Tokyo, Japan in February, supporting the technology company's growth strategy in the key senior care and automotive markets - Vayyar's touchless senior care technology is deployed in facilities and private homes around the world, providing activity moni...
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow
SHANGHAI, Feb. 22, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial results...
Nippon Express Obtains GDP Certification for Temperature-controlled Facility at Kansai International Airport
TOKYO, Feb. 22, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification, effectiveJanuary 11, for NX-PHARMA Logistics Hub Kansai Airport, a temperature-controlled fa...
Nanoform 4Q and full year 2021 report: accelerating GMP growth
HELSINKI, Feb. 22, 2022 /PRNewswire/ -- The strong momentum continues: first two customer GMP projects signed, full-year gross margin exceeds 2025 target, the rapid growth in orders received and revenue recognized accelerates further, the first clear signs of economics of scale emerges, while the...
Winner Silver Alginate Dressing has Obtained 510K Code in the USA
SHENZHEN, China, Feb. 21, 2022 /PRNewswire/ -- Recently, the silver alginate dressing of Winner Medical (300888.SZ) receives U.S. FDA market access (510K Number: K202982), marking that this product has obtained the qualification to get into the access US market and Winner Medical will further e...
Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts
CHENGDU, China, Feb. 21, 2022 /PRNewswire/ -- Revotek announced that it has
received clearance from the National Health Commission ofChina to begin a
clinical study in the West China Hospital,Chengdu, with its first stem cell 3D
bioprinting product, REVOVAS.
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment ofAlmira Chabi, M.D. as Chief Medical Officer and Chief Development Officer at HanAll Pharmaceutical International (HPI), a U.S. entity wholly owned by HanAll Biopharma, to strengt...
Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development
* Recorded operating profit KRW 88.9 billion and net profit KRW 31.6 billion in 2021 with the outcome of its relentless focus on R&D * Attributed to export upswing of Nabota, KRW 1.1 trillion overseas technology transfer of Fexuclue tablets, and growth of highly profitable ETC drugs SEOUL, So...
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2)in Frontiers in Immunology
NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 21, 2022 /PRNewswire/ -- recently -- Adlai Nortye Ltd. ("Adlai Nortye"), a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced the publication of preclinical research of AN3025 (anti-hTNFR2)...
Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that China National Medical Products Administration (NMPA) had approved its investigational new drug (IND) application for HBM9378 (or SKB378 as referred to ...
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia™) has been approved by the Joint Prevention and Control Mechanism ...
VISTA Eye Specialists works with Tzu Chi Malaysia to Help Restore Eyesight with 100 Charity Cataract Surgery
PETALING JAYA, Malaysia, Feb. 21, 2022 /PRNewswire/ -- In conjunction with World Sight Day 2021, VISTA Eye Specialist (VISTA) is continuing to support the fight towards eliminating preventable blindness by pledging to provide 100 Charity Cataract surgeries via a joint community service project wi...
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345
SAN FRANCISCO and SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
Meihua International Medical Technologies Co., Ltd. Announces Closing of $39.4 Million Initial Public Offering
YANGZHOU, China, Feb. 18, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced the closing of...
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 318 media titles]
2024-05-15 12:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 301 media titles]
2024-05-16 15:00US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 272 media titles]
2024-05-16 09:39Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01